Nicholas Investment Partners’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-219,483
Closed -$13.8M 214
2020
Q4
$13.8M Buy
219,483
+457
+0.2% +$28.4K 1.07% 30
2020
Q3
$14.7M Buy
219,026
+172,174
+367% +$9.4M 1.59% 19
2020
Q2
$1.96M Sell
46,852
-57,030
-55% -$2.19M 0.4% 99
2020
Q1
$3.27M Sell
103,882
-16,825
-14% -$674K 0.64% 64
2019
Q4
$4.87M Sell
120,707
-8,489
-7% -$297K 0.5% 58
2019
Q3
$4.2M Buy
129,196
+36,873
+40% +$1.47M 0.35% 112
2019
Q2
$4.47M Buy
+92,323
New +$3.93M 0.41% 87

Other funds holding SILK

Nicholas Investment Partners's SILK Position: Q1 2021 in Review

Nicholas Investment Partners sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2021, closing a stake of 219,483 shares — an estimated $13.8M sold.

Nicholas Investment Partners first reported a position in SILK in Q2 2019 and held it in 7 quarters. The position peaked at $14.7M in Q3 2020. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • Nicholas Investment Partners reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Nicholas Investment Partners sold 219,483 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $13.8M.
  • Nicholas Investment Partners first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Nicholas Investment Partners's Silk Road Medical, Inc. Common Stock position peaked at $14.7M in Q3 2020.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on Nicholas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.